HMD Develops Dispojekt To Help Reduce Needle Stick Injuries

New Delhi: Hindustan Syringes and Medical Devices (HMD) has launched first-of-its kind Dispojekt single use syringes with safety needle, which further strengthens India’s position in becoming global powerhouse in medical devices.

With the revolutionary Dispojekt safety syringes, HMD aims to reduce prevalence of accidental Needle Stick Injuries (NSIs) among health workers, reduction of infection control cost and that of disposal and training, offering a long term positive financial impact on the healthcare sector. Domestic manufactured, technologically advanced products will provide India a global edge in the realm of R&D and leapfrog indigenous players to meet the highly demanding global market for sharp injury prevention syringes.

The use of safety needles in healthcare settings offer numerous cost benefits. They reduce healthcare worker injuries, lowering costs from potential disease treatment and potential long-term health issues. By minimising needle stick injuries, they also decrease expenses for post-exposure prophylaxis and associated healthcare costs. Moreover, safety needles mitigate compensation claims, absenteeism, and can lead to lower health insurance premiums, while also reducing product and packaging footprints for cost and environmental savings. They assist in creating a safer and more reliable workplace environment for healthcare workers.

According to research, the prevalence of NSIs among healthcare workers in India is between 57% and 73%. In fact, approximately 54% of NSIs are reported because of using hypodermic needles. Many instances of NSIs go unreported, making it a way more serious problem than it appears.

Related Posts

18 maternal deaths still a ‘mystery’, says Rajasthan health minister

JAIPUR: Three months after Rajasthan first began reporting clusters of maternal fatalities at state-run hospitals, the govt has still no explanation so far of what caused the deaths of 18 women…

FDA suspends licence of Pune’s Metro Blood Bank; 10 district blood centres face action

FDA officials said the approved technical supervisor at the bank had resigned in March 2025, but blood component separation allegedly continued without an approved replacement. Pune: The Maharashtra Food and…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

18 maternal deaths still a ‘mystery’, says Rajasthan health minister

18 maternal deaths still a ‘mystery’, says Rajasthan health minister

FDA suspends licence of Pune’s Metro Blood Bank; 10 district blood centres face action

FDA suspends licence of Pune’s Metro Blood Bank; 10 district blood centres face action

Health Ministry Unveils Thalassemia Awareness Posters to Promote Early Screening

Health Ministry Unveils Thalassemia Awareness Posters to Promote Early Screening

Employees are Apples of ENTOD’s Eyes, few fall Far from Tree

Employees are Apples of ENTOD’s Eyes, few fall Far from Tree

After two years, pharma volumes pick up pace

After two years, pharma volumes pick up pace

NPPA fixes prices of 39 drugs, raises anti-rabies immunoglobulin rate

NPPA fixes prices of 39 drugs, raises anti-rabies immunoglobulin rate